Big Banks Pass "Stress Test" & Earnings Expectations for Financials

All 32 banks in the Fed's stress test passed, which Stephen Biggar says is a positive signal for the sector heading into earnings season. He highlighted expectations for major banks including JPMorgan Chase, Wells Fargo, and Bank of America, implying constructive fundamentals and stable capital strength. The piece is largely an analyst-driven read-through rather than a fresh company-specific earnings event.

Analysis

The clean stress-test result removes an important overhang for the group, but the bigger second-order effect is on capital return psychology: when the Fed signals resilience, management teams tend to become more aggressive on buybacks and dividend messaging into earnings. That is most supportive for JPM and BAC, where excess capital and operating leverage can convert into a near-term rerating if revenue stability holds; WFC benefits too, but its story remains more balance-sheet repair and expense discipline than outright upside torque.

The likely near-term winner is JPM because investors are paying for consistency, not just capital strength. If rates stay high enough to keep net interest income stable but not so high as to pressure deposit betas, JPM can compound through share repurchases while peers are still proving earnings durability. BAC has the cleaner operating leverage setup if trading and investment banking volumes re-accelerate, but it remains more sensitive to deposit mix and consumer credit normalization over the next 1-2 quarters.

The contrarian risk is that the market is treating “passing stress tests” as a clean read-through for earnings, when the real variable is not solvency but profitability under slower loan growth and sticky funding costs. A mild credit deterioration or deposit migration would not trigger a crisis, but it could compress the multiple by 1-2 turns if 3Q guidance disappoints. In that sense, the move is positive but potentially under-owned only if earnings revisions start to inflect upward; otherwise this is more of a sentiment tailwind than a fundamental re-rating catalyst.

Catalyst timing matters: the next 2-6 weeks should be about estimate revisions and capital-return updates, while the next 2-3 months will determine whether lower volatility and better fee income can offset slower lending. A risk-off macro tape would favor JPM relative to WFC/BAC because it can absorb weaker end-markets with less earnings variance. If the group rallies into earnings without upward revisions, that becomes a fade opportunity rather than a trend change.

Key Decisions for Investors

• Long JPM vs. BAC into earnings over the next 2-6 weeks: JPM should command a premium multiple if capital return and earnings stability dominate, while BAC has more upside to cycle improvement but greater downside if NII or deposit costs disappoint.
• Pair trade: long JPM / short WFC for the next quarter. JPM is the higher-quality compounder with better fee diversification; WFC still carries more execution risk and less optionality if the macro backdrop softens.
• Buy BAC on a pullback only if 3Q NII guidance holds and deposit costs stabilize. Risk/reward improves after the initial relief rally fades; upside could be meaningful, but near-term entry matters because the market may already be pricing the stress-test headline.
• Use call spreads on JPM into earnings rather than outright stock. The catalyst is positive but likely caps near-term upside unless revisions accelerate; a defined-risk structure captures a 5-8% rerating without overpaying for volatility.
• If the stocks rally pre-earnings and guidance is merely in-line, reduce exposure by 25-50%. The stress-test outcome is supportive, but without earnings upward revisions the trade shifts from catalyst-driven to valuation-limited.